Recent studies have demonstrated an important role for IL-5-dependent bone marrow
eosinophil progenitors in allergic inflammation. However, studies using anti-IL-5 mAbs in human …

Background Perceptions of high cost and resource intensity remain political barriers to the
prioritization of childhood cancer treatment programs in many low‐ and middle‐income …

Background Despite increasing global attention to non-communicable diseases (NCDs) and
their incorporation into universal health coverage (UHC), the factors that determine whether …

Objective Preferences of members of the public are recognized as important inputs into
health care priority-setting, though knowledge of such preferences is scant. We sought to …

Background Access to essential childhood cancer medicines is a core determinant of childhood
cancer outcomes. Available evidence, although scarce, suggests that access to these …

Cancer is the leading cause of disease-related death in children, adolescents, and young
adults beyond the newborn period in North America. Improving survival rates for patients with …

… Discrepancies were discussed and a third author (Sumit Gupta or Avram E. Denburg) was
involved in cases where consensus could not be reached. Possibly eligible studies were …

PURPOSE Access to essential cancer medicines is a major determinant of childhood cancer
outcomes globally. The degree to which pediatric oncologists deem medicines listed on …

Background: Public policy approaches to funding paediatric medicines in advanced health
systems remain understudied. In particular, the ethical and social values dimensions of …

‘The problem is small enough, the problem is big enough’: a qualitative study of health
technology assessment and public policy on drug funding decisions for children | International …